IVERIC bio Inc
ISEE
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.51B
Close$
$43.47
8.8% upside
Current Fair Value
8.8% upsideUndervalued by 8.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.51 Billion |
|---|---|
| Enterprise Value | $5.14 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.45 |
| Beta | 1.1 |
| Outstanding Shares | 137,087,000 |
Return
| Return on Equity | -44.47% |
|---|---|
| Return on Assets | -34.58% |
| Return on Invested Capital | -39.91% |
Valuation & Multiples
| P/E Ratio | -27.51 |
|---|---|
| PEG | -25.94 |
| Price to Sales | - |
| Price to Book Ratio | 13.32 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -22.44 |
| Enterprise Value to Net Income | -25 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.2 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About IVERIC bio Inc
CEO: Glenn Sblendorio